Published in Infect Immun on March 01, 2010
The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace. Front Microbiol (2012) 2.45
Phospholipase D: enzymology, functionality, and chemical modulation. Chem Rev (2011) 1.66
Acinetobacter baumannii: an emerging opportunistic pathogen. Virulence (2012) 1.63
Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity. PLoS One (2011) 1.56
Identification of an Acinetobacter baumannii zinc acquisition system that facilitates resistance to calprotectin-mediated zinc sequestration. PLoS Pathog (2012) 1.47
Acinetobacter baumannii utilizes a type VI secretion system for bacterial competition. PLoS One (2013) 1.19
Genomic comparison of multi-drug resistant invasive and colonizing Acinetobacter baumannii isolated from diverse human body sites reveals genomic plasticity. BMC Genomics (2011) 1.18
Innate immune responses to systemic Acinetobacter baumannii infection in mice: neutrophils, but not interleukin-17, mediate host resistance. Infect Immun (2011) 1.14
Genome organization of epidemic Acinetobacter baumannii strains. BMC Microbiol (2011) 1.12
Complete genome analysis of three Acinetobacter baumannii clinical isolates in China for insight into the diversification of drug resistance elements. PLoS One (2013) 1.10
Genome-wide identification of Acinetobacter baumannii genes necessary for persistence in the lung. MBio (2014) 1.08
Virulence-related traits of epidemic Acinetobacter baumannii strains belonging to the international clonal lineages I-III and to the emerging genotypes ST25 and ST78. BMC Infect Dis (2013) 1.08
Host-microbe interactions that shape the pathogenesis of Acinetobacter baumannii infection. Cell Microbiol (2012) 1.05
Resources for Genetic and Genomic Analysis of Emerging Pathogen Acinetobacter baumannii. J Bacteriol (2015) 1.04
Growth of Acinetobacter baumannii in pellicle enhanced the expression of potential virulence factors. PLoS One (2011) 1.03
Comparative analysis of surface-exposed virulence factors of Acinetobacter baumannii. BMC Genomics (2014) 1.01
Host fate is rapidly determined by innate effector-microbial interactions during Acinetobacter baumannii bacteremia. J Infect Dis (2014) 1.01
Identification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumannii. J Bacteriol (2012) 1.00
Genomic and functional analysis of the type VI secretion system in Acinetobacter. PLoS One (2013) 0.99
Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options. Semin Respir Crit Care Med (2015) 0.99
genetic determinants of intrinsic colistin tolerance in Acinetobacter baumannii. Infect Immun (2012) 0.98
The complete genome and phenome of a community-acquired Acinetobacter baumannii. PLoS One (2013) 0.97
Adenylate kinase release as a high-throughput-screening-compatible reporter of bacterial lysis for identification of antibacterial agents. Antimicrob Agents Chemother (2012) 0.97
H-NS plays a role in expression of Acinetobacter baumannii virulence features. Infect Immun (2013) 0.94
Validation of a novel murine wound model of Acinetobacter baumannii infection. Antimicrob Agents Chemother (2013) 0.94
A mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain. Antimicrob Agents Chemother (2013) 0.94
Imaging mass spectrometry for assessing temporal proteomics: analysis of calprotectin in Acinetobacter baumannii pulmonary infection. Proteomics (2013) 0.92
Genome sequencing and comparative analysis of three Chlamydia pecorum strains associated with different pathogenic outcomes. BMC Genomics (2014) 0.92
Effect of ethanol on differential protein production and expression of potential virulence functions in the opportunistic pathogen Acinetobacter baumannii. PLoS One (2012) 0.90
Platelet-activating factor receptor initiates contact of Acinetobacter baumannii expressing phosphorylcholine with host cells. J Biol Chem (2012) 0.89
Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside. World J Clin Cases (2014) 0.88
Radiation combined with thermal injury induces immature myeloid cells. Shock (2012) 0.87
The contribution of nutrient metal acquisition and metabolism to Acinetobacter baumannii survival within the host. Front Cell Infect Microbiol (2013) 0.86
Disruption of the phospholipase D gene attenuates the virulence of Aspergillus fumigatus. Infect Immun (2011) 0.86
Acinetobacter baumannii Virulence Is Mediated by the Concerted Action of Three Phospholipases D. PLoS One (2015) 0.84
Loss of mitochondrial protein Fus1 augments host resistance to Acinetobacter baumannii infection. Infect Immun (2013) 0.84
The innate immune protein calprotectin promotes Pseudomonas aeruginosa and Staphylococcus aureus interaction. Nat Commun (2016) 0.83
An ribonuclease T2 family protein modulates Acinetobacter baumannii abiotic surface colonization. PLoS One (2014) 0.83
Acinetobacter baumannii Genes Required for Bacterial Survival during Bloodstream Infection. mSphere (2015) 0.81
The FhaB/FhaC two-partner secretion system is involved in adhesion of Acinetobacter baumannii AbH12O-A2 strain. Virulence (2016) 0.80
Acinetobacter calcoaceticus-baumannii complex strains induce caspase-dependent and caspase-independent death of human epithelial cells. Curr Microbiol (2012) 0.80
Code blue: Acinetobacter baumannii, a nosocomial pathogen with a role in the oral cavity. Mol Oral Microbiol (2014) 0.80
Identification of Acinetobacter baumannii serum-associated antibiotic efflux pump inhibitors. Antimicrob Agents Chemother (2014) 0.79
Toll-Like Receptor 9 Contributes to Defense against Acinetobacter baumannii Infection. Infect Immun (2015) 0.79
Biochemical characterization of a Pseudomonas aeruginosa phospholipase D. Biochemistry (2015) 0.78
Use of Comparative Genomics To Characterize the Diversity of Acinetobacter baumannii Surveillance Isolates in a Health Care Institution. Antimicrob Agents Chemother (2016) 0.78
Small-molecule inhibitors of Staphylococcus aureus RnpA-mediated RNA turnover and tRNA processing. Antimicrob Agents Chemother (2015) 0.78
Genome-sequence analysis of Acinetobacter johnsonii MB44 reveals potential nematode-virulent factors. Springerplus (2016) 0.77
Discovery of desketoraloxifene analogues as inhibitors of mammalian, Pseudomonas aeruginosa, and NAPE phospholipase D enzymes. ACS Chem Biol (2014) 0.77
Moraxella catarrhalis expresses a cardiolipin synthase that impacts adherence to human epithelial cells. J Bacteriol (2013) 0.77
Repurposing the antihistamine terfenadine for antimicrobial activity against Staphylococcus aureus. J Med Chem (2014) 0.76
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges. Clin Microbiol Rev (2017) 0.76
Clinically Relevant Growth Conditions Alter Acinetobacter baumannii Antibiotic Susceptibility and Promote Identification of Novel Antibacterial Agents. PLoS One (2015) 0.76
Bacterial Sphingomyelinases and Phospholipases as Virulence Factors. Microbiol Mol Biol Rev (2016) 0.76
Iron-Regulated Phospholipase C Activity Contributes to the Cytolytic Activity and Virulence of Acinetobacter baumannii. PLoS One (2016) 0.76
The Secrets of Acinetobacter Secretion. Trends Microbiol (2017) 0.75
Critical role of bacterial isochorismatase in the autophagic process induced by Acinetobacter baumannii in mammalian cells. FASEB J (2016) 0.75
Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options. Front Cell Infect Microbiol (2017) 0.75
Global dynamic proteome study of a pellicle-forming Acinetobacter baumannii strain. Mol Cell Proteomics (2016) 0.75
RAGE-mediated suppression of IL-10 results in enhanced mortality in a murine model of Acinetobacter baumannii sepsis. Infect Immun (2017) 0.75
Dynamic Computational Model of Symptomatic Bacteremia to Inform Bacterial Separation Treatment Requirements. PLoS One (2016) 0.75
Maltodextrin enhances biofilm elimination by electrochemical scaffold. Sci Rep (2016) 0.75
Targeting phospholipase D in cancer, infection and neurodegenerative disorders. Nat Rev Drug Discov (2017) 0.75
Essential Oils and Their Components as Modulators of Antibiotic Activity against Gram-Negative Bacteria. Medicines (Basel) (2016) 0.75
Complexity of Complement Resistance Factors Expressed by Acinetobacter baumannii Needed for Survival in Human Serum. J Immunol (2017) 0.75
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol (2007) 10.18
Use of pulsed-field gel electrophoresis for investigation of hospital outbreaks of Acinetobacter baumannii. J Clin Microbiol (1992) 4.18
Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis (2007) 3.73
A novel family of phospholipase D homologues that includes phospholipid synthases and putative endonucleases: identification of duplicated repeats and potential active site residues. Protein Sci (1996) 3.34
Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology (2003) 3.26
Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol (1997) 2.91
Type II secretion: a protein secretion system for all seasons. Trends Microbiol (2005) 2.80
The long-distance tertiary air transfer and care of tsunami victims: injury pattern and microbiological and psychological aspects. Crit Care Med (2005) 2.62
Analysis and nucleotide sequence of an origin of DNA replication in Acinetobacter calcoaceticus and its use for Escherichia coli shuttle plasmids. Gene (1990) 2.52
Emerging gram-negative antibiotic resistance: daunting challenges, declining sensitivities, and dire consequences. Respir Care (2008) 2.47
Severe community-acquired pneumonia due to Acinetobacter baumannii. Chest (2001) 2.46
The vacB gene required for virulence in Shigella flexneri and Escherichia coli encodes the exoribonuclease RNase R. J Biol Chem (1998) 2.41
A duplicated catalytic motif in a new superfamily of phosphohydrolases and phospholipid synthases that includes poxvirus envelope proteins. Trends Biochem Sci (1996) 2.16
The inanimate environment of an intensive care unit as a potential source of nosocomial bacteria: evidence for long survival of Acinetobacter calcoaceticus. Infect Control Hosp Epidemiol (1989) 1.89
Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality. Medicine (Baltimore) (1995) 1.88
Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia. J Antimicrob Chemother (2007) 1.85
Identification and characterization of an Acinetobacter baumannii biofilm-associated protein. J Bacteriol (2007) 1.80
Mutations in multicopy Tn10 tet plasmids that confer resistance to inhibitory effects of inducers of tet gene expression. J Bacteriol (1983) 1.67
Genetic and biochemical analyses of a eukaryotic-like phospholipase D of Pseudomonas aeruginosa suggest horizontal acquisition and a role for persistence in a chronic pulmonary infection model. Mol Microbiol (2001) 1.59
Septic complications of war wounds. JAMA (1972) 1.58
Multicopy Tn10 tet plasmids confer sensitivity to induction of tet gene expression. J Bacteriol (1983) 1.56
Acinetobacter baumannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells. BMC Microbiol (2008) 1.50
The survival of Acinetobacter calcoaceticus inoculated on fingertips and on formica. J Hosp Infect (1990) 1.46
Pathogenesis of caseous lymphadenitis in sheep and goats. Aust Vet J (1986) 1.44
Hospital-acquired infections following the 1999 Marmara earthquake. J Hosp Infect (2002) 1.41
Extensively drug-resistant Acinetobacter baumannii. Emerg Infect Dis (2009) 1.34
Survival of bacteria under dry conditions; from a viewpoint of nosocomial infection. J Hosp Infect (1991) 1.27
Expression of phospholipase D, the major virulence factor of Corynebacterium pseudotuberculosis, is regulated by multiple environmental factors and plays a role in macrophage death. Microbiology (2007) 1.27
Cloning, nucleotide sequence, and expression in Escherichia coli of the phospholipase D gene from Corynebacterium pseudotuberculosis. J Bacteriol (1990) 1.23
Penicillin-binding protein 7/8 contributes to the survival of Acinetobacter baumannii in vitro and in vivo. J Infect Dis (2009) 1.22
Identification and characterization of a new enzyme of the group "phospholipase D" isolated from Corynebacterium ovis. Biochim Biophys Acta (1971) 1.18
Cold shock exoribonuclease R (VacB) is involved in Aeromonas hydrophila pathogenesis. J Bacteriol (2008) 1.11
Serum resistance and biofilm formation in clinical isolates of Acinetobacter baumannii. FEMS Immunol Med Microbiol (2009) 1.05
Efficacy of an ovine caseous lymphadenitis vaccine formulated using a genetically inactive form of the Corynebacterium pseudotuberculosis phospholipase D. Vaccine (1999) 1.03
Gonococcal phospholipase d modulates the expression and function of complement receptor 3 in primary cervical epithelial cells. Infect Immun (2003) 1.00
Purification and characterization of tissue factor apoprotein. Methods Enzymol (1976) 1.00
Management of purulent pericarditis. Monaldi Arch Chest Dis (2004) 0.89
The 3'-to-5' exoribonuclease (encoded by HP1248) of Helicobacter pylori regulates motility and apoptosis-inducing genes. J Bacteriol (2009) 0.89
E. coli growth inhibition by a high copy number derivative of plasmid pBR322. Biochem Biophys Res Commun (1996) 0.86
High expression of plasmid-encoded tetracycline resistance gene in E. coli causes a decrease in membrane-bound ATPase activity. Plasmid (1996) 0.83
Relation between the toxogenicity and pyogenicity of Corynebacterium ovis in experimentally infected mice. Res Vet Sci (1976) 0.82
[Phosphatidylcholine induces an increase in the production of interleukin-6 and improves survival of rats with neonatal sepsis caused by Klebsiella pneumoniae]. Gac Med Mex (1996) 0.78
Acinetobacter pericarditis with tamponade in a patient with systemic lupus erythematosus. Lupus (1997) 0.78
Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol (2006) 5.97
Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe (2007) 5.46
The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity (2010) 5.12
Passage of heme-iron across the envelope of Staphylococcus aureus. Science (2003) 4.83
Metal chelation and inhibition of bacterial growth in tissue abscesses. Science (2008) 4.55
The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity (2009) 4.51
Global gene expression in Staphylococcus aureus biofilms. J Bacteriol (2004) 4.46
Prospective, controlled, cross-over trial of alcohol-based hand gel in critical care units . Infect Control Hosp Epidemiol (2008) 4.03
Nutritional immunity: transition metals at the pathogen-host interface. Nat Rev Microbiol (2012) 3.55
Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. J Infect Dis (2010) 2.77
Iron in infection and immunity. Cell Host Microbe (2013) 2.77
Nutritional immunity beyond iron: a role for manganese and zinc. Curr Opin Chem Biol (2009) 2.69
Nutrient metal sequestration by calprotectin inhibits bacterial superoxide defense, enhancing neutrophil killing of Staphylococcus aureus. Cell Host Microbe (2011) 2.66
Zinc sequestration by the neutrophil protein calprotectin enhances Salmonella growth in the inflamed gut. Cell Host Microbe (2012) 2.66
A Staphylococcus aureus regulatory system that responds to host heme and modulates virulence. Cell Host Microbe (2007) 2.55
Staphylococcus aureus IsdB is a hemoglobin receptor required for heme iron utilization. J Bacteriol (2006) 2.54
Characterization of the Staphylococcus aureus heat shock, cold shock, stringent, and SOS responses and their effects on log-phase mRNA turnover. J Bacteriol (2006) 2.50
Designing a biocontainment unit to care for patients with serious communicable diseases: a consensus statement. Biosecur Bioterror (2006) 2.43
Transcriptional profiling of a Staphylococcus aureus clinical isolate and its isogenic agr and sarA mutants reveals global differences in comparison to the laboratory strain RN6390. Microbiology (2006) 2.36
Scalable signaling mediated by T cell antigen receptor-CD3 ITAMs ensures effective negative selection and prevents autoimmunity. Nat Immunol (2008) 2.34
Transcription Profiling of the mgrA Regulon in Staphylococcus aureus. J Bacteriol (2006) 2.08
Neutrophil microbicides induce a pathogen survival response in community-associated methicillin-resistant Staphylococcus aureus. J Immunol (2008) 1.97
Effect of mild acid on gene expression in Staphylococcus aureus. J Bacteriol (2004) 1.96
Treatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenza. J Infect Dis (2009) 1.93
N-linked glycosylation attenuates H3N2 influenza viruses. J Virol (2007) 1.92
Characterizing the effect of the Staphylococcus aureus virulence factor regulator, SarA, on log-phase mRNA half-lives. J Bacteriol (2006) 1.89
A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline. Antimicrob Agents Chemother (2005) 1.88
The nitrosative stress response of Staphylococcus aureus is required for resistance to innate immunity. Mol Microbiol (2006) 1.86
Comparative genomics of Staphylococcus aureus musculoskeletal isolates. J Bacteriol (2005) 1.85
A new sequence distance measure for phylogenetic tree construction. Bioinformatics (2003) 1.85
Staphylococcus aureus redirects central metabolism to increase iron availability. PLoS Pathog (2006) 1.81
Regulation of mprF in daptomycin-nonsusceptible Staphylococcus aureus strains. Antimicrob Agents Chemother (2009) 1.76
Direct targets of CodY in Staphylococcus aureus. J Bacteriol (2010) 1.76
PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology. PLoS Pathog (2010) 1.75
Overcoming the heme paradox: heme toxicity and tolerance in bacterial pathogens. Infect Immun (2010) 1.74
Intracellular metalloporphyrin metabolism in Staphylococcus aureus. Biometals (2007) 1.71
Specificity for human hemoglobin enhances Staphylococcus aureus infection. Cell Host Microbe (2010) 1.66
Molecular basis for manganese sequestration by calprotectin and roles in the innate immune response to invading bacterial pathogens. Proc Natl Acad Sci U S A (2013) 1.64
Staphylococcus aureus fur regulates the expression of virulence factors that contribute to the pathogenesis of pneumonia. Infect Immun (2010) 1.59
Monitoring the inflammatory response to infection through the integration of MALDI IMS and MRI. Cell Host Microbe (2012) 1.58
Influenza virus primes mice for pneumonia from Staphylococcus aureus. J Infect Dis (2011) 1.56
The α₂β₁ integrin is a metastasis suppressor in mouse models and human cancer. J Clin Invest (2010) 1.55
Molecular mechanisms of Staphylococcus aureus iron acquisition. Annu Rev Microbiol (2011) 1.51
Inflammasome-independent role of apoptosis-associated speck-like protein containing a CARD (ASC) in T cell priming is critical for collagen-induced arthritis. J Biol Chem (2010) 1.51
Bacterial sinusitis and otitis media following influenza virus infection in ferrets. Infect Immun (2006) 1.51
Recombination, repair and replication in the pathogenic Neisseriae: the 3 R's of molecular genetics of two human-specific bacterial pathogens. Mol Microbiol (2003) 1.48
Identification of an Acinetobacter baumannii zinc acquisition system that facilitates resistance to calprotectin-mediated zinc sequestration. PLoS Pathog (2012) 1.47
Ruffling of metalloporphyrins bound to IsdG and IsdI, two heme-degrading enzymes in Staphylococcus aureus. J Biol Chem (2008) 1.46
Melanocortin-4 receptor signaling is required for weight loss after gastric bypass surgery. J Clin Endocrinol Metab (2012) 1.46
Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300. PLoS Pathog (2012) 1.44
The IsdG-family of haem oxygenases degrades haem to a novel chromophore. Mol Microbiol (2010) 1.40
Staphylococcus aureus haem oxygenases are differentially regulated by iron and haem. Mol Microbiol (2008) 1.37
Signaling and DNA-binding activities of the Staphylococcus aureus HssR-HssS two-component system required for heme sensing. J Biol Chem (2007) 1.34
Staphylococcus aureus nonribosomal peptide secondary metabolites regulate virulence. Science (2010) 1.33
Characterization of the Staphylococcus aureus CidR regulon: elucidation of a novel role for acetoin metabolism in cell death and lysis. Mol Microbiol (2006) 1.32
Viral acute lower respiratory infections impair CD8+ T cells through PD-1. J Clin Invest (2012) 1.31
The Staphylococcus aureus LytSR two-component regulatory system affects biofilm formation. J Bacteriol (2009) 1.31
A secreted bacterial protease tailors the Staphylococcus aureus virulence repertoire to modulate bone remodeling during osteomyelitis. Cell Host Microbe (2013) 1.31
Staphylococcal vaccines and immunotherapy: to dream the impossible dream? Curr Opin Pharmacol (2006) 1.30
A new oxidative sensing and regulation pathway mediated by the MgrA homologue SarZ in Staphylococcus aureus. Mol Microbiol (2008) 1.25
Phialosimplex, a new anamorphic genus associated with infections in dogs and having phylogenetic affinity to the Trichocomaceae. Med Mycol (2010) 1.24
RAIphy: phylogenetic classification of metagenomics samples using iterative refinement of relative abundance index profiles. BMC Bioinformatics (2011) 1.23
Subcellular localization of the Staphylococcus aureus heme iron transport components IsdA and IsdB. Infect Immun (2009) 1.18
Characterization of components of the Staphylococcus aureus mRNA degradosome holoenzyme-like complex. J Bacteriol (2011) 1.18
Golden pigment production and virulence gene expression are affected by metabolisms in Staphylococcus aureus. J Bacteriol (2010) 1.18
MntABC and MntH contribute to systemic Staphylococcus aureus infection by competing with calprotectin for nutrient manganese. Infect Immun (2013) 1.17
Two heme-dependent terminal oxidases power Staphylococcus aureus organ-specific colonization of the vertebrate host. MBio (2013) 1.17
Outbreak of bloodstream infection temporally associated with the use of an intravascular needleless valve. Clin Infect Dis (2007) 1.16
Messenger RNA Turnover Processes in Escherichia coli, Bacillus subtilis, and Emerging Studies in Staphylococcus aureus. Int J Microbiol (2009) 1.15
Metal limitation and toxicity at the interface between host and pathogen. FEMS Microbiol Rev (2014) 1.14
Staphylococcus aureus HrtA is an ATPase required for protection against heme toxicity and prevention of a transcriptional heme stress response. J Bacteriol (2008) 1.13
Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity. Semin Immunopathol (2011) 1.13
A battle for iron: host sequestration and Staphylococcus aureus acquisition. Microbes Infect (2011) 1.12
Control of copper resistance and inorganic sulfur metabolism by paralogous regulators in Staphylococcus aureus. J Biol Chem (2011) 1.12
Geographic factors contributing to a high seroprevalence of West Nile virus-specific antibodies in humans following an epidemic. Clin Vaccine Immunol (2006) 1.12
Structural basis for hemoglobin capture by Staphylococcus aureus cell-surface protein, IsdH. J Biol Chem (2011) 1.11
Advancing translational research. Science (2011) 1.11
Small molecule inhibitors of Staphylococcus aureus RnpA alter cellular mRNA turnover, exhibit antimicrobial activity, and attenuate pathogenesis. PLoS Pathog (2011) 1.10
Bacillus anthracis HssRS signalling to HrtAB regulates haem resistance during infection. Mol Microbiol (2009) 1.10
Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse model. Haematologica (2010) 1.10
Seroprevalence of seasonal and pandemic influenza A viruses in domestic cats. Arch Virol (2010) 1.09
Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice. Am J Respir Crit Care Med (2010) 1.09
Immunopathogenic and antibacterial effects of H3N2 influenza A virus PB1-F2 map to amino acid residues 62, 75, 79, and 82. J Virol (2011) 1.09
RAF265 inhibits the growth of advanced human melanoma tumors. Clin Cancer Res (2012) 1.09
Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations. Antimicrob Agents Chemother (2009) 1.08
The heme sensor system of Staphylococcus aureus. Contrib Microbiol (2009) 1.08
Staphylococcus aureus ClpC divergently regulates capsule via sae and codY in strain newman but activates capsule via codY in strain UAMS-1 and in strain Newman with repaired saeS. J Bacteriol (2010) 1.08
The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniae. Antimicrob Agents Chemother (2005) 1.07
PCR rapidly detects methicillin-resistant staphylococci periprosthetic infection. Clin Orthop Relat Res (2003) 1.07
Host-microbe interactions that shape the pathogenesis of Acinetobacter baumannii infection. Cell Microbiol (2012) 1.05